REVVITY, INC Foreign Currency Transaction Gain (Loss), Unrealized
REVVITY, INC (RVTY) reported Foreign Currency Transaction Gain (Loss), Unrealized of -$186.00 thousand for the 6-month period ending 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2026-08-11
- REVVITY, INC foreign currency transaction gain (loss), unrealized for the quarter ending 2026-07-05 was -$86.00K.
- REVVITY, INC foreign currency transaction gain (loss), unrealized for the quarter ending 2026-04-05 was -$100.00K, a 251.52% decline year-over-year.
- REVVITY, INC foreign currency transaction gain (loss), unrealized for the quarter ending 2025-12-28 was -$51.00K.
- REVVITY, INC foreign currency transaction gain (loss), unrealized for the quarter ending 2025-09-28 was -$82.00K, a 139.81% decline year-over-year.
- REVVITY, INC foreign currency transaction gain (loss), unrealized for fiscal 2025 was -$273.00K, a 125.78% decline from fiscal 2024.
- REVVITY, INC foreign currency transaction gain (loss), unrealized for fiscal 2024 was $1.06M.
- REVVITY, INC foreign currency transaction gain (loss), unrealized for fiscal 2023 was -$24.09M.
- REVVITY, INC foreign currency transaction gain (loss), unrealized for fiscal 2023 was $0.00.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2026-07-05 | -$86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$186.00K 10-Q · filed 2026-08-11 | -$237.00K derived: sum of 3 quarters · filed 2026-08-11 | -$319.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-04-05 | -$100.00K 10-Q · filed 2026-05-12 | -$151.00K derived: sum of 2 quarters · filed 2026-05-12 | -$233.00K derived: sum of 3 quarters · filed 2026-05-12 | -$439.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-28 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$133.00K derived: sum of 2 quarters · filed 2026-02-24 | -$339.00K derived: sum of 3 quarters · filed 2026-08-11 | -$273.00K 10-K · filed 2026-02-24 |
| 2025-09-28 | -$82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$288.00K derived: sum of 2 quarters · filed 2026-08-11 | -$222.00K 10-Q · filed 2025-11-04 | -$226.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-29 | -$206.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$140.00K 10-Q · filed 2026-08-11 | -$144.00K derived: sum of 3 quarters · filed 2026-08-11 | $62.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-30 | $66.00K 10-Q · filed 2026-05-12 | $62.00K derived: sum of 2 quarters · filed 2026-05-12 | $268.00K derived: sum of 3 quarters · filed 2026-05-12 | $748.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-29 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $202.00K derived: sum of 2 quarters · filed 2026-02-24 | $682.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.06M 10-K · filed 2026-02-24 |
| 2024-09-29 | $206.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $686.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.06M 10-Q · filed 2025-11-04 | $653.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $480.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $857.00K 10-Q · filed 2025-08-05 | $447.00K derived: sum of 3 quarters · filed 2026-02-24 | $447.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $377.00K 10-Q · filed 2025-05-06 | -$33.00K derived: sum of 2 quarters · filed 2026-02-24 | -$33.00K derived: sum of 3 quarters · filed 2026-02-24 | $2.38M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$410.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$410.00K derived: sum of 2 quarters · filed 2026-02-24 | $2.01M derived: sum of 3 quarters · filed 2026-02-24 | -$24.09M 10-K · filed 2026-02-24 |
| 2023-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.42M derived: sum of 2 quarters · filed 2024-11-06 | -$23.68M 10-Q · filed 2024-11-06 | |
| 2023-07-02 | $2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$23.68M 10-Q · filed 2024-08-06 | ||
| 2023-04-02 | -$26.09M 10-Q · filed 2024-05-07 | |||
| 2023-01-01 | $0.00 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |